Pharmaceuticals, health and wellness

Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic condition kdunleavy Fri, 03/18/2022 – 18:13 Source link

Pfizer CEO Bourla scored big raise in 2021—to $24M—as drugmaker played a leading pandemic role esagonowsky Fri, 03/18/2022 – 14:40 Source link

After Pfizer’s pitch for 2nd round of COVID boosters, Moderna files a more ambitious FDA submission kdunleavy Fri, 03/18/2022 – 11:16 Source link

Pfizer’s deal with Medicines Patent Pool includes 35 companies from 12 countries to produce generic Paxlovid kdunleavy Fri, 03/18/2022 – 09:33 Source link

Fierce Pharma Asia—Eisai’s reduced Aduhelm role; Chinese biotechs’ US delisting risks; Zai Lab’s new COO from Lilly aliu Fri, 03/18/2022 – 06:28 Source link

Amid sales slump, Teva CEO Schultz’s pay falls 7% to $14.7M kdunleavy Thu, 03/17/2022 – 19:38 Source link

Merck details Keytruda’s postsurgery lung cancer win, teeing up fight against Roche’s Tecentriq aliu Thu, 03/17/2022 – 11:52 Source link

Alnylam sues Pfizer and Moderna claiming infringement on its delivery technology for COVID shots kdunleavy Thu, 03/17/2022 – 11:32 Source link

Ahead of Humira’s patent cliff, AbbVie’s Rinvoq notches third new use in 4 months kdunleavy Thu, 03/17/2022 – 09:44 Source link

Biogen’s Tecfidera patent contingency plan falls flat amid sputtering Aduhelm launch fkansteiner Thu, 03/17/2022 – 09:13 Source link

After Alexion buyout, AstraZeneca pays Roche $775M to settle Ultomiris patent brawl aliu Thu, 03/17/2022 – 08:53 Source link

Bristol Myers’ Opdivo aide Opdualag scores FDA approval in melanoma, opens 3rd immune checkpoint drug class aliu Thu, 03/17/2022 – 06:26 Source link